Cesare Astori

2.0k total citations · 1 hit paper
29 papers, 1.0k citations indexed

About

Cesare Astori is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Cesare Astori has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 15 papers in Hematology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Cesare Astori's work include Lymphoma Diagnosis and Treatment (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Acute Myeloid Leukemia Research (7 papers). Cesare Astori is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers) and Acute Myeloid Leukemia Research (7 papers). Cesare Astori collaborates with scholars based in Italy and Austria. Cesare Astori's co-authors include Mario Lazzarino, Elisa Rumi, Emanuela Boveri, Mario Cazzola, Cristiana Pascutto, Daniela Pietra, Emanuela Sant’Antonio, Ilaria Carola Casetti, Virginia Valeria Ferretti and Chiara Milanesi and has published in prestigious journals such as Blood, Cancer and British Journal of Haematology.

In The Last Decade

Cesare Astori

28 papers receiving 1000 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

2013 391 citations Elisa Rumi, Daniela Pietra et al. Blood profile →

Peers

Countries citing papers authored by Cesare Astori

Since Specialization

Citations

This map shows the geographic impact of Cesare Astori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cesare Astori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cesare Astori more than expected).

Fields of papers citing papers by Cesare Astori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cesare Astori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cesare Astori. The network helps show where Cesare Astori may publish in the future.

Co-authorship network of co-authors of Cesare Astori

This figure shows the co-authorship network connecting the top 25 collaborators of Cesare Astori. A scholar is included among the top collaborators of Cesare Astori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cesare Astori. Cesare Astori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnosis and management of prefibrotic myelofibrosis 2018 ·Expert Review of Hematology ·Elisa Rumi, Emanuela Sant’Antonio, Emanuela Boveri, Daniela Pietra, Chiara Cavalloni, Elisa Roncoroni, Cesare Astori, Luca Arcaini	12
2	Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasms 2017 ·Oncotarget ·Chiara Cavalloni, Elisa Rumi, Virginia Valeria Ferretti, Daniela Pietra, Elisa Roncoroni, Marta Bellini, (unknown), Ilaria Carola Casetti, (unknown), (unknown), (unknown), Cesare Astori, Mario Cazzola	6
3	JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes breakdown → 2013 ·Blood ·Elisa Rumi, Daniela Pietra, Virginia Valeria Ferretti, Thorsten Klampfl, Ashot S. Harutyunyan, Jelena D. Milosevic Feenstra, Nicole C.C. Them, Tiina Berg, Chiara Elena, Ilaria Carola Casetti, Chiara Milanesi, Emanuela Sant’Antonio, Marta Bellini, (unknown), (unknown), Emanuela Boveri, Cesare Astori, Cristiana Pascutto, Róbert Královics, Mario Cazzola	391
4	JAK2 (V617F)-Positive Essential Thrombocythemia and Polycythemia Vera Are Different Expressions Of a Genotypic/Phenotypic Continuum 2013 ·Blood ·Elisa Rumi, Daniela Pietra, Chiara Elena, Ilaria Carola Casetti, (unknown), Cesare Astori, Chiara Milanesi, Marta Bellini, Emanuela Boveri, Virginia Valeria Ferretti, Cristiana Pascutto, Mario Cazzola	0
5	Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms 2013 ·Blood ·Elisa Rumi, Daniela Pietra, Paola Guglielmelli, Roberta Bordoni, Ilaria Carola Casetti, Chiara Milanesi, Emanuela Sant’Antonio, Virginia Valeria Ferretti, Alessandro Pancrazzi, Giada Rotunno, Marco Severgnini, Alessandro Pietrelli, Cesare Astori, (unknown), Cristiana Pascutto, Emanuela Boveri, Francesco Passamonti, Gianluca De Bellis, Alessandro M. Vannucchi, Mario Cazzola	73
6	Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome 2012 ·Cancer Genetics ·(unknown), Marina Boni, Marianna Rossi, Patrizia Zappasodi, (unknown), Rita Zappatore, Paola Maria Cavigliano, Ilaria Giardini, Barbara Rocca, Marilena Caresana, Cesare Astori, Mario Cazzola, Carlo Castagnola, Paolo Bernasconi	4
7	Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires 2009 ·Blood Cells Molecules and Diseases ·Luca Arcaini, Silvia Zibellini, Francesco Passamonti, Sara Rattotti, Marco Lucioni, Rosangela Invernizzi, Michele Merli, Silvia Rizzi, Emanuela Boveri, Elisa Rumi, Cesare Astori, Cristina Picone, Marzia Varettoni, Cristiana Pascutto, Marco Paulli, Mario Lazzarino	23
8	High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma 2009 ·Human Pathology ·Francesca Novara, Luca Arcaini, Michele Merli, Francesco Passamonti, Silvia Zibellini, Silvia Rizzi, Sara Rattotti, Elisa Rumi, Cristiana Pascutto, Annalisa Vetro, Cesare Astori, Emanuela Boveri, Marco Lucioni, Marco Paulli, Orsetta Zuffardi, Mario Lazzarino	12
9	Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia 2006 ·American Journal of Hematology ·Elisa Rumi, Francesco Passamonti, Emanuela Boveri, Mara De Amici, Cesare Astori, (unknown), Carlo Castagnola, Umberto Magrini, Mario Cazzola, Mario Lazzarino	28
10	Long‐term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance 2002 ·British Journal of Haematology ·Paolo Bernasconi, Paola Maria Cavigliano, Marina Boni, Cesare Astori, Silvia Calatroni, Ilaria Giardini, Barbara Rocca, Marilena Caresana, Nicola Crosetto, Mario Lazzarino, Carlo Bernasconi	12
11	Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis 2002 ·British Journal of Haematology ·Francesco Passamonti, Lucia Malabarba, Ester Orlandi, Cristiana Pascutto, Ercole Brusamolino, Cesare Astori, Claudia Baratè, (unknown), Alessandro Corso, Paolo Bernasconi, Mario Cazzola, Mario Lazzarino	29
12	Rituximab (IDEC-C2B8): Validation of a Sensitive Enzyme-Linked Immunoassay Applied to a Clinical Pharmacokinetic Study 2000 ·Therapeutic Drug Monitoring ·I Iacona, Mario Lazzarino, Maria Antonietta Avanzini, Maurizio Rupolo, Luca Arcaini, Cesare Astori, (unknown), Ester Orlandi, Enrica Morra, Vittorina Zagonel, Mario Regazzi	58
13	Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity. 2000 ·PubMed ·Ercole Brusamolino, Francesca Lunghi, Ester Orlandi, Cesare Astori, Francesco Passamonti, Claudia Baratè, G. Pagnucco, (unknown), (unknown), Mario Lazzarino, Carlo Bernasconi	58
14	The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders 1999 ·British Journal of Haematology ·Mario Lazzarino, Ester Orlandi, Fausto Baldanti, Milena Furione, G. Pagnucco, Cesare Astori, Luca Arcaini, Alessandra Viglio, Marco Paulli, Giuseppe Gerna, Carlo Bernasconi	47
15	Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity. 1998 ·PubMed ·Mario Lazzarino, Ester Orlandi, Catherine Klersy, Cesare Astori, Ercole Brusamolino, Alessandro Corso, Laura Bellio, Livio Gargantini, Enrica Morra, Carlo Bernasconi	42
16	Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphoma 1998 ·Cancer ·Mario Lazzarino, Ester Orlandi, Catherine Klersy, Cesare Astori, Ercole Brusamolino, Alessandro Corso, Laura Bellio, Livio Gargantini, Enrica Morra, Carlo Bernasconi	5
17	Serum CA 125 is of clinical value in the staging and follow-up of patients with non-hodgkin's lymphoma 1998 ·Cancer ·Mario Lazzarino, Ester Orlandi, Catherine Klersy, Cesare Astori, Ercole Brusamolino, Alessandro Corso, Laura Bellio, Livio Gargantini, Enrica Morra, Carlo Bernasconi	27
18	Treatment with recombinant human erythropoietin (rHuEpo) in a patient with paroxysmal nocturnal haemoglobinuria: evaluation of membrane proteins CD55 and CD59 with cytofluorometric assay 1997 ·British Journal of Haematology ·Cesare Astori, Maurizio Bonfichi, G. Pagnucco, Paolo Bernasconi, Mario Lazzarino, Ester Orlandi, Carlo Bernasconi	6
19	Nodular Lymphocyte Predominance Hodgkin's Disease: Long-Term Observation Reveals a Continuous Pattern of Recurrence 1997 ·Leukemia & lymphoma ·Ester Orlandi, Mario Lazzarino, Ercole Brusamolino, Marco Paulli, Cesare Astori, Umberto Magrini, Carlo Bernasconi	39
20	Splenic marginal zone cell lymphoma involving liver and bone marrow. Report of a case with protracted follow-up, showing progressive disappearance of the lymphoma after splenectomy. 1996 ·PubMed ·R. Rosso, A Castello, (unknown), Cesare Astori, Mario Lazzarino, Umberto Magrini	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact